[Antibodies to sarcolysine and 5-fluorouracil].
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001491:Basophils / Q000276:immunology; D003429:Cross Reactions / Q000187:drug effects; D004407:Dysgerminoma / Q000188:drug therapy / Q000276:immunology; D004912:Erythrocytes / Q000187:drug effects / Q000276:immunology; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000276:immunology; D005472:Fluorouracil / Q000009:adverse effects*; D006386:Hemagglutination Tests; D006801:Humans; D007114:Immunization; D007158:Immunologic Techniques; D007271:Injections, Intradermal; D007275:Injections, Intravenous; D008297:Male; D008558:Melphalan / Q000009:adverse effects*; D011817:Rabbits; D051381:Rats; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000276:immunology; D013997:Time Factors
D008558:Melphalan; D005472:Fluorouracil
Antitela k sarkolizinu i 5-ftoruratsilu